logo

For the Inventor, By the Inventor

Reading, MA, United States of America

Matthew J LaMarche

USPTO Granted Patents = 30 

 

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 100(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2001 - 2005)
  • Reading, MA (US) (2005 - 2024)

Company Filing History:

goldMedal22 out of 3,923 
 
Novartis Ag
 patents
silverMedal5 out of 2,597 
 
University of Pennsylvania
 patents
bronzeMedal2 out of 850 
 
Millennium Pharmaceuticals Limited
 patents
4. 1 out of 4,179 
 
Abbott Laboratories Corporation
 patents
5. 1 out of 2,893 
 
The General Hospital Corporation
 patents
where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents
1. 12209098 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2025-01-28),
2. 12053470 - Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitor (2024-08-06),
3. 11952386 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2024-04-09),
4. 11905283 - Compounds and compositions for inhibiting the activity of SHP2 (2024-02-20),
5. 11401259 - 1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 (2022-08-02),
6. 10975080 - Compounds and compositions for inhibiting the activity of SHP2 (2021-04-13),
7. 10968235 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2021-04-06),
8. 10934285 - Compounds and compositions for inhibiting the activity of SHP2 (2021-03-02),
9. 10774065 - 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 (2020-09-15),
10. 10336774 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2019-07-02),
11. 10308660 - Compounds and compositions for inhibiting the activity of SHP2 (2019-06-04),
12. 10301278 - 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 (2019-05-28),
13. 10287266 - Compounds and compositions for inhibiting the activity of SHP2 (2019-05-14),
14. 10130629 - Pharmaceutical combinations (2018-11-20),
15. 10093646 - 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 (2018-10-09),

Title: The Inventor Matthew J LaMarche

Introduction: Matthew J LaMarche is a talented inventor based in Reading, MA (US) known for his innovative contributions in various fields.

Latest Patents: Matthew J LaMarche holds several patents in the areas of technology and engineering, showcasing his dedication to pushing the boundaries of innovation.

Career Highlights: Throughout his career, Matthew J LaMarche has demonstrated a keen ability to transform ideas into practical solutions, earning him recognition as a forward-thinker in the industry.

Collaborations: Matthew J LaMarche has collaborated with leading experts and organizations to further his inventions, highlighting his commitment to teamwork and shared success.

Conclusion: Matthew J LaMarche's passion for innovation and his impressive track record make him a standout figure in the world of inventors, with a promising future ahead.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…